Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Times Interest Earned (2020 - 2021)

VYNE Therapeutics' Times Interest Earned history spans 2 years, with the latest figure at -$3.1 for Q3 2021.

  • For Q3 2021, Times Interest Earned rose 85.59% year-over-year to -$3.1; the TTM value through Jun 2022 reached -$10.53, up 28.64%, while the annual FY2021 figure was -$6.94, 87.94% up from the prior year.
  • Times Interest Earned reached -$3.1 in Q3 2021 per VYNE's latest filing, up from -$8.88 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$3.1 in Q3 2021 to a low of -$156.24 in Q2 2020.